Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Intravenous infusion of recombinant tissue plasminogen activator for the treatment of patients with sudden and/or chronic hearing loss.

Mora R, Barbieri M, Mora F, Mora M, Yoo TJ.

Ann Otol Rhinol Laryngol. 2003 Aug;112(8):665-70.

PMID:
12940661
2.

Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.

Diefenbach C, Erbel R, Pop T, Mathey D, Schofer J, Hamm C, Ostermann H, Schmitz-Hübner U, Bleifeld W, Meyer J.

Am J Cardiol. 1988 May 1;61(13):966-70. Review.

PMID:
2452563
3.

Drug variables in thrombolytic therapy.

Meyerovitz MF.

J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):62S-65S. Review.

PMID:
8770844
4.

Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients.

Zadeh MH, Storper IS, Spitzer JB.

Otolaryngol Head Neck Surg. 2003 Jan;128(1):92-8. Review.

PMID:
12574765

Supplemental Content

Support Center